UNIVERSITE CLAUDE BERNARD LYON 1;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;NETRIS PHARMA;PASCALE NONY;CENTRE LEON BERARD;ANDREA PARADISI;PATRICK MEHLEN
发明人:
PATRICK MEHLEN,ANDREA PARADISI,PASCALE NONY
申请号：
IL23770215
公开号：
IL237702A
申请日:
2015.03.12
申请国别(地区):
IL
年份:
2018
代理人:
摘要：
Pharmaceutical composition comprising a chemotherapeutic drug and a netrin-1 interfering drug or a vector capable of expressing a netrin-1 interfering drug in vivo, in a pharmaceutically acceptable carrier or vehicle. The chemotherapeutic drug is selected from those able to induce over expression of netrin-1 in cancer cells. The combination is associated with synergic anti-cancer effect.
